首页> 外文期刊>Aesthetic plastic surgery >Comparison of Volume Retention and Biocompatibility of Acellular Dermal Matrix/Hyaluronic Acid Filler to Autologous Fat Grafts in a Mouse Model
【24h】

Comparison of Volume Retention and Biocompatibility of Acellular Dermal Matrix/Hyaluronic Acid Filler to Autologous Fat Grafts in a Mouse Model

机译:小鼠模型中无细胞真皮基质/透明质酸填料对自体脂移植物的体积保留和生物相容性的比较

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background Although fat grafting has become a widely used technique in aesthetic and reconstructive surgeries, resorption is still a challenge. Micronized acellular dermal matrix (ADM) has been considered as a stable, biocompatible soft tissue coverage material that can be used as a volume filler. Here, we compared the bioacceptance and sustainability of ADM hyaluronic acid (HA) filler with human fat graft in a mouse model. Methods Harvested human fat and ADM/HA filler were injected randomly on the dorsal side of mice. Thirty-two mice were analyzed over a 7-week period with respect to volume, weight and microscopic evaluations with hematoxylin and eosin (H&E), epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) staining. Results The volume and weight were maintained at 80% and 83%, respectively, in the ADM/HA filler group and 56.5% and 49.7%, respectively, in the fat-grafted group by the 7th week. There were no significant microscopic differences in inflammatory changes and granulation via H&E staining. At 1 and 2 weeks, EGF and VEGF immunostaining intensity scores were lower in the ADM/HA filler group. At 7 weeks, there were no significant differences in immunostaining intensity scores between the two groups. Conclusions During the 7-week experimental period, the ADM/HA filler showed no foreign body reaction and the proper volume was well maintained. This suggests that the ADM/HA filler can possibly be used in small amounts as an alternative to autologous fat grafts. No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors.
机译:背景技术虽然脂肪嫁接已成为审美和重建手术中的广泛使用的技术,但吸收仍然是一项挑战。微粉化的无细胞皮肤基质(ADM)被认为是一种稳定的生物相容性软组织覆盖材料,可用作体积填料。在这里,我们将Adm透明质酸(HA)填料与小鼠模型中的人脂移植进行了比较了ADM透明质酸(HA)的可持续性。方法在小鼠的背侧随机注射收获的人脂肪和ADM / HA填料。在7周的时间内分析了三十两只小鼠,相对于血毒素和曙红(H&E),表皮生长因子(EGF)和血管内皮生长因子(VEGF)染色的体积,重量和微观评估分析了7周的时间。结果在第7周,分别在Adm / HA填料组中分别在80%和83%和56.5%和49.7%中维持在80%和83%。通过H&E染色没有显着的显微镜差异和肿瘤造粒。在1和2周,EGF和VEGF免疫染色强度分数在AD / HA填料组中较低。在7周,两组之间的免疫染色强度得分无显着差异。结论在7周实验期间,ADM / HA填料显示出异物反应并保持适当的体积保持良好。这表明ADM / HA填料可能以少量使用,作为自体脂肪移植物的替代品。分配了本期刊的级别要求提交人为每份提交的证据级别达成一定程度的证据。这不包括审查文章,书籍评论和稿件,涉及基础科学,动物研究,尸体研究和实验研究。有关这些循证医学评级的完整描述,请参阅内容表或向作者的在线说明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号